Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

SHA:603456 Revenue

Zhejiang Jiuzhou Pharmaceutical had revenue of 1.36B CNY in the quarter ending September 30, 2026, with 5.58% growth. This brings the company's total for the last twelve months to 5.28B, down -1.33% year-over-year. In the year 2025, Zhejiang Jiuzhou Pharmaceutical had annual revenue of 5.51B with 6.74% growth. That makes Zhejiang Jiuzhou Pharmaceutical the 8,784th largest company in the world by revenue and 1,366th in China.

• Revenue (ttm): 5.28B
• Revenue Growth: -1.33%
• P/S Ratio: 2.63
• Revenue / Employee: 1.10M
• Employees: 4,791
• Market Cap: 13.88B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Patented APIs and Intermediates 4.18B 77.1%
• Specialty APIs (Active Pharmaceutical Ingredients) and Intermediates 1.16B 21.4%
• Others 80.94M 1.5%

By Geography

Chart

• Export 4.23B 78.1%
• China 1.18B 21.9%

Fiscal year ended Dec 31, 2025 See the full SHA:603456 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.51B	348.01M	6.74%
Dec 31, 2024	5.16B	-362.83M	-6.57%
Dec 31, 2023	5.52B	78.31M	1.44%
Dec 31, 2022	5.45B	1.38B	34.01%
Dec 31, 2021	4.06B	1.42B	53.48%

Data Source: S&P Global Market Intelligence Last updated: Oct 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error